INCEPTOR BIO

inceptor-bio-logo

Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers, with a focus on novel mechanisms to improve immune cell performance in the tumor microenvironment. Inceptor Bio provides a partnership model to university research programs focused on cutting-edge therapeutic approaches for oncology. The combination of their lab and manufacturing resources with the industry experience of their cell and gene therapy experts will advance therapeutics into the clinic with remarkable efficiency.

#SimilarOrganizations #People #Financial #Website #More

INCEPTOR BIO

Social Links:

Industry:
Biotechnology Health Care Wellness

Founded:
2020-01-01

Address:
Raleigh, North Carolina, United States

Country:
United States

Website Url:
http://www.inceptor.bio

Total Employee:
1+

Status:
Active

Contact:
(919) 521-6400

Email Addresses:
[email protected]

Total Funding:
71.77 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Amazon Microsoft Azure DNS Cloudflare JS CDN JS GoDaddy DNS


Similar Organizations

hebecell-logo

HebeCell

HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.

pandion-therapeutics-logo

Pandion Therapeutics

Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.

phyla-logo

Phyla

Phyla is developing alternative therapies for antibiotics.

providence-therapeutics-logo

Providence Therapeutics

Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.


Current Advisors List

frank-lis_image

Frank Lis Advisor @ Inceptor Bio
Advisor
2021-06-01

Current Employees Featured

derek-hennecke_image

Derek Hennecke
Derek Hennecke Partner @ Inceptor Bio
Partner
2017-07-01

not_available_image

Abe Maingi
Abe Maingi VP, Business Development, Board of Directors, Co-Founder @ Inceptor Bio
VP, Business Development, Board of Directors, Co-Founder
2020-08-01

shailesh-maingi_image

Shailesh Maingi
Shailesh Maingi Founder and CEO @ Inceptor Bio
Founder and CEO
2020-01-01

Founder


not_available_image

Abe Maingi

shailesh-maingi_image

Shailesh Maingi

Investors List

kineticos-ventures_image

Kineticos Ventures

Kineticos Ventures investment in Series A - Inceptor Bio

kineticos-disruptor-fund_image

Kineticos Disruptor Fund

Kineticos Disruptor Fund investment in Seed Round - Inceptor Bio

Official Site Inspections

http://www.inceptor.bio Semrush global rank: 3.67 M Semrush visits lastest month: 3.82 K

  • Host name: 73.133.208.35.bc.googleusercontent.com
  • IP address: 35.208.133.73
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Inceptor Bio"

Inceptor Bio - Crunchbase Company Profile & Funding

Inceptor Bio may be growing as evidenced by the successful spinout of Kincell, a contract development manufacturing organization (CDMO), which originated from Inceptor Bio's operations. This strategic move has led to Kincell being valued โ€ฆSee details»

About Us - Inceptor Bio

Prior to Inceptor Bio, Dr. Nicholson spent nearly 13 years at Precision BioSciences, where he held several leadership roles, including Executive Director of Scientific Operations, Vice President โ€ฆSee details»

Inceptor Bio Company Profile 2024: Valuation, Funding โ€ฆ

Inceptor Bio General Information Description. Operator of a biotechnology platform designed for advancing research and developing therapies to cure cancer. The company's platform identifies, incubates, and accelerates novel โ€ฆSee details»

Inceptor Bio - LinkedIn

Inceptor Bio | 4,211 followers on LinkedIn. Advancing Cell and Gene Therapies to Cure Cancer | Inceptor Bio is developing multiple next-generation cell therapy platforms to cure difficult-to โ€ฆSee details»

A Novel Approach to Drive Disruptive Innovation in โ€ฆ

Oct 22, 2021 Inceptor Bio is increasing the likelihood of success in a challenging field by building multiple companies and platforms instead of building out an organization entirely dedicated to a single technology. With an impressive โ€ฆSee details»

Inceptor Bio and GRIT Bio Announce Strategic Partnership to โ€ฆ

4 days ago About Inceptor Bio Inceptor Bio, founded in May 2020 and headquartered in Research Triangle Park, NC, is dedicated to advancing next-generation cell and gene โ€ฆSee details»

Inceptor Bio Licenses Solid Tumor CAR T-Cell Therapy to Grit Bio โ€ฆ

2 days ago Inceptor, which launched in 2020, also owns a portfolio of companies focused on different cell therapy platforms and disease areas, including FastBack Bio, which focuses on โ€ฆSee details»

Inceptor Bio - Funding, Financials, Valuation & Investors

Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. ... How much โ€ฆSee details»

Inceptor Bio to use $37M series A to nudge CAR-T into โ€ฆ

May 19, 2022 Inceptor Bio will use proceeds from a $37 million series A round to push its lead CAR-T program into phase 1 trials in 2023 and set up manufacturing capability in Florida.See details»

Inceptor Bio - Pharma's Almanac

How Does Inceptor Bio Envision the Future of the Pharma/Biopharma Industry? Inceptor Bio. PAP-Q4-20-RT2-002 Dec 09, 2020. CGT Visualizing the Future of Contract Development and โ€ฆSee details»

The Latest - Inceptor Bio

Inceptor Bio and GRIT Bio Announce Strategic Partnership to Advance IB-T101, a Next-Generation Solid Tumor CAR-T Utilizing the OUTLASTโ„ข Platform December 18, 2024 Read โ€ฆSee details»

Inceptor Bio Company Profile - Office Locations, Competitors

Inceptor Bio has 5 employees at their 1 location and $37 m in total funding,. See insights on Inceptor Bio including office locations, competitors, revenue, financials, executives, โ€ฆSee details»

Inceptor: building persistence of cancer cell therapies

May 20, 2022 On Thursday, Inceptor Bio LLC announced a $37 million series A round led by Kineticos Venture, which gives the biotech about two years of runway to advance a lead CAR โ€ฆSee details»

Inceptor Bio and GRIT Bio Announce Strategic Partnership to โ€ฆ

3 days ago Inceptor Bio, a leading innovator in cell therapy, and GRIT Bio, a clinical-stage immunotherapy developer, today announced a strategic partnership to advance IB-T101, a โ€ฆSee details»

Ori Biotech and Inceptor Bio partner to accelerate solid tumor cell ...

Dec 15, 2022 Inceptor Bio is a biotechnology company developing multiple next-generation cell therapy products to deliver cures for underserved and difficult-to-treat cancers. Inceptor Bio is โ€ฆSee details»

Inceptor Bio - Contacts, Employees, Board Members ... - Crunchbase

Organization. Inceptor Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board โ€ฆSee details»

Inceptor Bio - Overview, News & Similar companies - ZoomInfo

Oct 12, 2022 Who is Inceptor Bio. Founded in 2020, Inceptor Bio is biotechnology company developing multiple next-generation cell and gene therapy platforms to deliver cures for und โ€ฆSee details»

Inceptor Bio - VentureRadar

Inceptor Bioโ€™s vision is to improve the way difficult-to-cure cancers are treated, changing patientsโ€™ lives with breakthrough cell and gene therapies. We provide a unique partnership model to โ€ฆSee details»

Inceptor Bio LLC - BioCentury Company Profiles - BCIQ

Jul 26, 2023 Inceptor Bio LLC - BioCentury Company Profiles for the biopharma industrySee details»

linkstock.net © 2022. All rights reserved